Sos, Martin L <br/><br/>
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Oct 2009 
 - 18351-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0907325106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Genotype<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology